JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 27 No. 12 1819-1823
© 1986 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonard, J.-P.
Right arrow Articles by Neirinckx, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonard, J.-P.
Right arrow Articles by Neirinckx, R. D.

Technetium-99m-d,1-HM-PAO: A New Radiopharmaceutical for Imaging Regional Brain Perfusion Using SPECT—A Comparison with Iodine-123 HIPDM

Jean-Pol Leonard, David P. Nowotnik and Rudi D. Neirinckx

Clinique du Parc Leopold, Centre de Medizin Nuclear, 1040 Brussels, Belgium
Amersham International plc, Pharmaceuticals Research and Development, Amersham, Buckinghamshire, England

Correspondence: For reprints contact: J. P. Leonard, MD, Clinique du Parc Leopold, Centre de Medizin Nuclear, rue Froyssard 38, 1040 Brussels, Belgium.

ABSTRACT

A new radiopharmaceutical, technetium-99m hexamethylpropyleneamine oxime (99mTc-d, 1-HM-PAO), has been reported to cross the blood-brain-barrier and to distribute in brain in proportion to regional blood flow. This study reports brain imaging obtained with 99mTc-d,1 HM-PAO in 20 subjects; seven without evidence of cerebral disease and 13 with cerebrovascular disorders. In 16 patients comparative data were available with N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-ioclobenzyl)-1,3-propanediamine (123II]HIPDM). Technetium-99m-d,1-HM-PAO is retained sufficiently long to allow single photon emission computed tomography (SPECT) with widely available rotating gamma camera systems. The kinetics demonstrated a rapid brain uptake and prolonged retention of activity in cerebral structures. Good tomographic images are obtained with much higher uptake in gray than in white matter. Blood flow maps are comparable to those achieved with [123I]HIPDM and established strokes were clearly seen, with similar details as in HIPDM studies. Delayed studies showed that the distribution in the brain remained virtually unchanged. Technetium-99m-d,1-HM-PAO imaging appears particularly promising in routine examination of patients with cerebrovascular disorders.




This article has been cited by other articles:


Home page
StrokeHome page
P. Laloux, J. Jamart, H. Meurisse, P. De Coster, and C. Laterre
Persisting Perfusion Defect in Transient Ischemic Attacks : A New Clinically Useful Subgroup?
Stroke, March 1, 1996; 27(3): 425 - 430.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1986 by the Society of Nuclear Medicine.